NEW YORK, NY / ACCESSWIRE / December 16, 2021 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) to Pfizer Inc. for $100.00 per share in cash is fair to Arena shareholders.
![Halper Sadeh LLP, Thursday, December 16, 2021, Press release picture](https://www.accesswire.com/users/newswire/images/678051/image.png)
Halper Sadeh encourages Arena shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
The investigation concerns whether Arena and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Arena shareholders; (2) determine whether Pfizer is underpaying for Arena; and (3) disclose all material information necessary for Arena shareholders to adequately assess and value the merger consideration. On behalf of Arena shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh encourages Arena shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
SOURCE: Halper Sadeh LLP